Unresolved disorder model. using A ATOM 248 CG ALEU 32 -7.993 29.583 1.455 0.50 19.78 C Unresolved disorder model. using A ATOM 249 CD1ALEU 32 -8.441 31.005 1.604 0.50 21.42 C Unresolved disorder model. using A ATOM 250 CD2ALEU 32 -8.225 29.025 0.081 0.50 23.43 C Unresolved disorder model. using A ATOM 251 CG BLEU 32 -6.727 30.273 0.653 0.50 17.36 C Unresolved disorder model. using A ATOM 252 CD1BLEU 32 -7.439 29.561 -0.441 0.50 16.58 C Unresolved disorder model. using A ATOM 253 CD2BLEU 32 -7.324 31.629 0.911 0.50 17.27 C Unknown residue CSW: ATOM 1357 N CSW 177 -9.895 26.438 35.761 1.00 17.07 N Unknown residue CSW: ATOM 1358 CA CSW 177 -10.263 27.839 35.836 1.00 19.06 C Unknown residue CSW: ATOM 1359 CB CSW 177 -9.060 28.756 36.011 1.00 18.58 C Unknown residue CSW: ATOM 1360 SG CSW 177 -9.293 30.421 35.933 1.00 25.94 S Unknown residue CSW: ATOM 1361 C CSW 177 -11.039 28.198 34.610 1.00 18.95 C Unknown residue CSW: ATOM 1362 O CSW 177 -10.712 27.854 33.501 1.00 21.01 O Unknown residue CSW: ATOM 1363 OD1 CSW 177 -11.006 31.011 36.603 1.00 44.78 O Unknown residue CSW: ATOM 1364 OD2 CSW 177 -7.731 31.093 36.573 1.00 34.54 O Unresolved disorder model. using A ATOM 1642 CG ALEU 212 -1.729 19.411 36.964 0.50 14.80 C Unresolved disorder model. using A ATOM 1643 CD1ALEU 212 -1.723 20.838 36.483 0.50 15.97 C Unresolved disorder model. using A ATOM 1644 CD2ALEU 212 -3.049 19.007 37.605 0.50 15.57 C Unresolved disorder model. using A ATOM 1645 CG BLEU 212 -2.362 19.347 35.753 0.50 12.92 C Unresolved disorder model. using A ATOM 1646 CD1BLEU 212 -3.666 18.802 36.327 0.50 12.37 C Unresolved disorder model. using A ATOM 1647 CD2BLEU 212 -2.079 20.702 36.277 0.50 13.85 C Unresolved disorder model. using A ATOM 1762 CG1AVAL 226 3.041 27.854 44.733 0.60 18.43 C Unresolved disorder model. using A ATOM 1763 CG2AVAL 226 4.652 29.673 44.218 0.60 21.06 C Unresolved disorder model. using A ATOM 1764 CG1BVAL 226 5.105 29.116 45.879 0.40 19.37 C Unresolved disorder model. using A ATOM 1765 CG2BVAL 226 3.171 27.715 45.035 0.40 18.42 C Unresolved disorder model. using A ATOM 1810 OG ASER 232 -10.515 27.883 45.091 0.60 23.68 O Unresolved disorder model. using A ATOM 1811 OG BSER 232 -10.517 26.708 47.551 0.40 21.54 O Unresolved disorder model. using A ATOM 1817 CG AMET 233 -7.718 26.490 41.081 0.60 20.43 C Unresolved disorder model. using A ATOM 1818 SD AMET 233 -8.034 27.532 39.693 0.60 25.30 S Unresolved disorder model. using A ATOM 1819 CE AMET 233 -7.081 28.958 40.154 0.60 21.80 C Unresolved disorder model. using A ATOM 1820 CG BMET 233 -7.951 26.604 41.258 0.40 17.75 C Unresolved disorder model. using A ATOM 1821 SD BMET 233 -6.550 27.043 40.370 0.40 17.83 S Unresolved disorder model. using A ATOM 1822 CE BMET 233 -7.203 27.148 38.719 0.40 14.24 C Unresolved disorder model. using A ATOM 1934 CG AGLN 246 13.225 19.976 39.649 0.60 21.28 C Unresolved disorder model. using A ATOM 1935 CD AGLN 246 13.923 19.150 40.688 0.60 23.94 C Unresolved disorder model. using A ATOM 1936 OE1AGLN 246 15.111 18.928 40.553 0.60 28.06 O Unresolved disorder model. using A ATOM 1937 NE2AGLN 246 13.232 18.757 41.742 0.60 24.45 N Unresolved disorder model. using A ATOM 1938 CG BGLN 246 13.312 19.943 39.655 0.40 20.78 C Unresolved disorder model. using A ATOM 1939 CD BGLN 246 13.345 19.165 38.350 0.40 24.06 C Unresolved disorder model. using A ATOM 1940 OE1BGLN 246 13.748 19.696 37.299 0.40 26.06 O Unresolved disorder model. using A ATOM 1941 NE2BGLN 246 12.891 17.909 38.404 0.40 23.07 N Unresolved disorder model. using A ATOM 1955 CG APHE 248 14.116 27.956 36.546 0.60 18.73 C Unresolved disorder model. using A ATOM 1956 CD1APHE 248 13.481 28.828 35.718 0.60 19.40 C Unresolved disorder model. using A ATOM 1957 CD2APHE 248 13.354 27.080 37.324 0.60 20.02 C Unresolved disorder model. using A ATOM 1958 CE1APHE 248 12.138 28.888 35.697 0.60 21.42 C Unresolved disorder model. using A ATOM 1959 CE2APHE 248 12.019 27.155 37.323 0.60 21.38 C Unresolved disorder model. using A ATOM 1960 CZ APHE 248 11.400 28.064 36.505 0.60 19.16 C Unresolved disorder model. using A ATOM 1961 CG BPHE 248 14.125 27.929 36.377 0.40 16.23 C Unresolved disorder model. using A ATOM 1962 CD1BPHE 248 13.489 27.375 35.267 0.40 16.22 C Unresolved disorder model. using A ATOM 1963 CD2BPHE 248 13.368 28.494 37.332 0.40 13.14 C Unresolved disorder model. using A ATOM 1964 CE1BPHE 248 12.132 27.437 35.127 0.40 15.75 C Unresolved disorder model. using A ATOM 1965 CE2BPHE 248 11.982 28.549 37.172 0.40 13.44 C Unresolved disorder model. using A ATOM 1966 CZ BPHE 248 11.395 28.015 36.086 0.40 12.87 C Unresolved disorder model. using A ATOM 2085 OG ASER 264 12.059 33.363 37.693 0.50 14.28 O Unresolved disorder model. using A ATOM 2086 OG BSER 264 11.121 31.776 38.462 0.50 15.93 O Unresolved disorder model. using A ATOM 2092 CG AGLN 265 9.956 36.785 37.012 0.50 14.28 C Unresolved disorder model. using A ATOM 2093 CD AGLN 265 10.496 38.183 36.800 0.50 15.86 C Unresolved disorder model. using A ATOM 2094 OE1AGLN 265 9.746 39.119 36.859 0.50 19.84 O Unresolved disorder model. using A ATOM 2095 NE2AGLN 265 11.772 38.309 36.520 0.50 17.36 N Unresolved disorder model. using A ATOM 2096 CG BGLN 265 9.865 36.787 37.090 0.50 13.30 C Unresolved disorder model. using A ATOM 2097 CD BGLN 265 10.124 38.290 37.193 0.50 13.93 C Unresolved disorder model. using A ATOM 2098 OE1BGLN 265 9.857 38.872 38.220 0.50 17.52 O Unresolved disorder model. using A ATOM 2099 NE2BGLN 265 10.672 38.880 36.155 0.50 12.28 N 1